NDC 0010-6737-01 - Disal
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0010-6737
- Requested NDC
- 0010-6737-01
- Package NDCs from labels
- 0010-6737-01
- Manufacturer
- Boehringer Ingelheim Animal Health USA Inc.
- Effective date
- 2025-04-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Disal® (furosemide injection) 50 mg/mL | Boehringer Ingelheim Animal Health USA Inc. | 2025-04-28 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0010-6737-01 | Disal | 100 mL in 1 VIAL, MULTI-DOSE | INJECTION | 100 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | DISAL (FUROSEMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | DISAL (FUROSEMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | DISAL (FUROSEMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| MONOETHANOLAMINE | INACTIVE INGREDIENT | 5KV86114PT | DISAL (FUROSEMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| MYRISTYL-.GAMMA.-PICOLINIUM CHLORIDE | INACTIVE INGREDIENT | 3D6CWI0P23 | DISAL (FUROSEMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | DISAL (FUROSEMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| SODIUM SULFITE | INACTIVE INGREDIENT | VTK01UQK3G | DISAL (FUROSEMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | DISAL (FUROSEMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | d75ba8bd-9494-4306-8443-9c1a90992dd5 | 2026-10-26 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Normal Salt | SODIUM CHLORIDE | GRAXCELL PHARMACEUTICAL, LLC | f3f09817-8a38-4aa1-956b-69d9cf695074 | 2026-10-26 | Warnings | 451W47IQ8X |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 5e37f97b-f5db-23a0-e063-6394a90a9b72 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 5e38ad23-ac84-e936-e063-6394a90ae351 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 48d8f490-e9d1-4c95-ab2f-414d3f4a9df4 | 2026-10-16 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Cardinal Health 107, LLC | 2590ebb6-ce2a-4e23-9244-e54e3010d488 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | c24489c3-65e0-44e3-a50a-8bb0672e8821 | 2026-10-14 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 52e75604-5766-40e8-a13a-8c449e06ebda | 2026-10-14 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 12137a90-fb35-45d7-8984-0b04793d3e34 | 2026-10-14 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.